Free. Unsubscribe any time.
GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC filed 24 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 61 transactions and 846,420 shares. 24 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-16, came 16 days after the one before it (2026-06-30) and reports 3 transactions against 6 in the filing before it.
- The sales it reports total 16,250 shares, 13,750 fewer than the 30,000 in the filing before it.
- Its 24 plan statements rank 11th of the 21 companies the register carries in Nevada, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 24 filings on file run from 2025-09-15 to 2026-07-16, and state 4 plan adoption dates, from 2025-04-17 to 2026-02-02.
Trades in GALECTIN THERAPEUTICS INC 61
- CALLICUTT JACK W — 2025-09-12 · S · 8,706 shares
- LEWIS JOEL — 2025-09-12 · S · 14,000 shares
- CALLICUTT JACK W — 2025-11-03 · S · 1,300 shares
- CALLICUTT JACK W — 2025-11-03 · S · 1,260 shares
- CALLICUTT JACK W — 2025-11-03 · S · 1,250 shares
- LEWIS JOEL — 2025-11-03 · S · 1,300 shares
- CALLICUTT JACK W — 2025-11-04 · S · 8,914 shares
- CALLICUTT JACK W — 2025-11-04 · S · 8,974 shares
- CALLICUTT JACK W — 2025-11-04 · S · 10,741 shares
- LEWIS JOEL — 2025-11-04 · S · 14,420 shares
- CALLICUTT JACK W — 2025-11-05 · S · 200 shares
- CALLICUTT JACK W — 2025-11-05 · S · 200 shares
Adoption dates in GALECTIN THERAPEUTICS INC 4
- 2025-04-17 — stated in 14 filings
- 2025-07-15 — stated in 3 filings
- 2025-08-29 — stated in 2 filings
- 2026-02-02 — stated in 4 filings
Results prints in GALECTIN THERAPEUTICS INC 7
- 2025-03-31
- 2025-05-15
- 2025-08-14
- 2025-11-14
- 2026-03-31
- 2026-05-15
- 2026-08-14
Trades before a print in GALECTIN THERAPEUTICS INC 8
- 1 day before the 2025-11-14 print — 2025-11-13 · S · Jamil Khurram · 21,867 shares
- 1 day before the 2025-11-14 print — 2025-11-13 · S · Jamil Khurram · 41,500 shares
- 1 day before the 2025-11-14 print — 2025-11-13 · S · Jamil Khurram · 41,500 shares
- 1 day before the 2025-11-14 print — 2025-11-13 · S · Jamil Khurram · 16,250 shares
- 4 days before the 2025-11-14 print — 2025-11-10 · S · CALLICUTT JACK W · 1,880 shares
- 4 days before the 2025-11-14 print — 2025-11-10 · S · CALLICUTT JACK W · 1,675 shares
- 4 days before the 2025-11-14 print — 2025-11-10 · S · CALLICUTT JACK W · 1,736 shares
- 4 days before the 2025-11-14 print — 2025-11-10 · S · LEWIS JOEL · 1,867 shares
- 9 days before the 2025-11-14 print — 2025-11-05 · S · CALLICUTT JACK W · 200 shares
- 9 days before the 2025-11-14 print — 2025-11-05 · S · CALLICUTT JACK W · 200 shares
- 9 days before the 2025-11-14 print — 2025-11-05 · S · CALLICUTT JACK W · 200 shares
- 9 days before the 2025-11-14 print — 2025-11-05 · S · LEWIS JOEL · 200 shares
Interval to GALECTIN THERAPEUTICS INC’s next reported results date
How the interval and sources are counted →
- 8within 5 days
- 16within 10 days
- 1shortest, days
- 0no later print
- CALLICUTT JACK W 2025-11-04 · S · 10 days before the 2025-11-14 print · Chief Financial Officer
- CALLICUTT JACK W 2025-11-04 · S · 10 days before the 2025-11-14 print · Chief Financial Officer
- CALLICUTT JACK W 2025-11-04 · S · 10 days before the 2025-11-14 print · Chief Financial Officer
- LEWIS JOEL 2025-11-04 · S · 10 days before the 2025-11-14 print · President and CEO
- CALLICUTT JACK W 2025-11-05 · S · 9 days before the 2025-11-14 print · Chief Financial Officer
- CALLICUTT JACK W 2025-11-05 · S · 9 days before the 2025-11-14 print · Chief Financial Officer
- CALLICUTT JACK W 2025-11-05 · S · 9 days before the 2025-11-14 print · Chief Financial Officer
- LEWIS JOEL 2025-11-05 · S · 9 days before the 2025-11-14 print · President and CEO
- CALLICUTT JACK W 2025-11-10 · S · 4 days before the 2025-11-14 print · Chief Financial Officer
- CALLICUTT JACK W 2025-11-10 · S · 4 days before the 2025-11-14 print · Chief Financial Officer
- CALLICUTT JACK W 2025-11-10 · S · 4 days before the 2025-11-14 print · Chief Financial Officer
- LEWIS JOEL 2025-11-10 · S · 4 days before the 2025-11-14 print · President and CEO
- Jamil Khurram 2025-11-13 · S · 1 day before the 2025-11-14 print · Chief Medical Officer
- Jamil Khurram 2025-11-13 · S · 1 day before the 2025-11-14 print · Chief Medical Officer
- Jamil Khurram 2025-11-13 · S · 1 day before the 2025-11-14 print · Chief Medical Officer
- Jamil Khurram 2025-11-13 · S · 1 day before the 2025-11-14 print · Chief Medical Officer
Adoption dates GALECTIN THERAPEUTICS INC states
- 2025-04-17 in 14 filings
- 2025-07-15 in 3 filings
- 2025-08-29 in 2 filings
- 2026-02-02 in 4 filings
Filing text: “10b5-1 plan adopted by the reporting person on April 17, 2025”
Reported results dates on file
- 2025-03-31
- 2025-05-15
- 2025-08-14
- 2025-11-14
- 2026-03-31
- 2026-05-15
- 2026-08-14
A proxy statement is on file for this company in the same window (2025-10-22), which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.